4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004772
Chief Financial Officer sold 50,000 shares at an average $68.61 ($3,430,421)
- Chief Financial Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Sale | −17,634 | $66.97 | $1,180,949 | 33,366 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Sale | −4,581 | $67.75 | $310,363 | 28,785 | D: show line 3 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Sale | −6,695 | $69.00 | $461,955 | 22,090 | D: show line 4 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Sale | −14,201 | $69.74 | $990,378 | 7,889 | D: show line 5 in the form |
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Sale | −6,889 | $70.66 | $486,777 | 1,000 | D: show line 6 in the form |
| Open-market sales · 50,000 sh · avg $68.61 · $3,430,421 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-19 | Option exercise · Stock Option (Right To Buy) | −50,000 | 315,000 | D: show line 7 in the form |
Loading xslF345X03/doc4.xml…